Congratulations to Dr. Peter Lansdorp (Lansdorp Lab), along with Dr. Kasmintan Schrader and Dr. Steven Jones, for being awarded a Canadian Institutes of Health Research (CIHR) Project Grant for the project titled “Parent-Of-Origin-Aware Genomic Analysis in Hereditary Cancer."
Congratulations to Dr. Peter Stirling (Stirling Lab) for being awarded a Canadian Institutes of Health Research (CIHR) Project Grant for the project titled “Dominant genetics of cohesion pathway proteins to kill cancer."
Congratulations to Dr. Kwangjin Park of Hoodless Lab for being retroactively awarded a Natural Sciences and Engineering Research Council of Canada (NSERC) 2022 Post Doctoral Fellowship. This compliments his 2022 Michael Smith Health Research BC Fellowship.
Researchers at the BC Cancer Research Institute have made an advancement in genetic testing that allows for more accurate prediction of which parent’s genes led to an individual’s increased cancer risk. This improves the efficiency of familial testing strategies and could eliminate concern for patients at high risk of cancer caused by genes inherited from a parent.
The BC Cancer Excellence Awards provide an opportunity to shine a light on the inspiring people and teams who help ensure that British Columbians receive world-class, patient-centred cancer screening, treatment and support, and benefit from new discoveries that are helping change the face of cancer.
Dr. Arefeh Rouhi is a doctor and scientist, research at the Terry Fox Laboratories, BC Cancer Research Institute. She is the winner of this year’s BC Cancer Excellence Award in the category of Workplace Inspiration.
The BCCF Innovation Support Fund Awardees are:
The BC Cancer Foundation, in partnership with BC Cancer, established the Innovation Support Fund competition in 2010 to enable the acquisition of equipment essential to conducting research.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.